RCAS1 Decidual Immunoreactivity in Severe Pre-Eclampsia: Immune Cell Presence and Activity

Authors


Lukasz Wicherek, Department of Gynecology, Obstetrics and Oncology of the Jagiellonian University 23 Kopernika Str, 31-501 Krakow, Poland.
E-mail: mowicher@cyf-kr.edu.pl

Abstract

Problem

Pre-eclampsia seems to be related to the disturbance of immune tolerance regulation during pregnancy. Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) decidual level alterations were concomitant with changes in immune cell number and activity in decidua. As decidual immunomodulating activity participates in the development of immune tolerance during pregnancy, we aimed to evaluate the immunoreactivity level of decidual RCAS1 with respect to the presence and activity of immune cells.

Method of study

RCAS1, CD3, CD56, CD69, and CD25 immunoreactivity was assessed by immunohistochemistry in 30 decidual samples derived from patients with severe pre-eclampsia (sPE) and from a healthy control group.

Results

RCAS1 immunoreactivity was statistically significantly higher in decidual tissue samples derived from patients with sPE tissue than in those derived from healthy patients in whom elective cesarean section at term was performed. A statistically significantly lower number of CD56+ and CD3+ cells and lower immunoreactivity level of CD69 were found in patients with sPE compared with those from the control group.

Conclusion

The limited immune cells infiltration in decidua during sPE is associated with increase in RCAS1 decidual level.

Ancillary